Morningstar had already identified almost $22.5bn of Anthropic exposure across publicly available investment portfolios worldwide before the company began trading on Nasdaq. That is institutional exposure that already exists. The prospective demand now being discussed is different: London-based index analytics firm Intropic estimates that index-tracking funds could purchase shares equivalent to as much as 30 per cent of Anthropic’s outstanding stock by the end of 2026. One figure describes positions already held; the other anticipates purchases that have yet to materialize.[1, 2]
The distinction has become particularly relevant after Anthropic’s first two trading sessions. Shares opened at $111.50 on November 19, climbed to approximately $115 and finished at $97.17. On November 20, they reached an intraday low of $83.10, approximately 14.5 per cent below the previous close and just $0.10 above the $83 offering price. Almost all the initial trading gains had disappeared.[3, 4]
The potential source of support is not a single institutional buying event. Different index providers operate separate admission schedules, creating several opportunities for Anthropic to attract passive ownership. CRSP and FTSE Russell can fast-track qualifying IPOs after five trading days. MSCI applies a 10-day waiting period, while Nasdaq's fast-entry process can produce an addition after 15 trading days. Standard S&P index eligibility requires at least 12 months of trading history.[1]
These schedules do not guarantee purchases. For CRSP, FTSE Russell and MSCI, minimum-size assessments depend partly on the value of shares available to public investors rather than the company's entire market capitalization. Russell's separate fast-entry provision requires an IPO to exceed a specified investable-market-capitalization threshold. Nasdaq applies a different test, requiring a qualifying company to rank among the 40 largest constituents by full market capitalization.[1, 5]
Index eligibility creates several routes to passive demand, but none guarantees a meaningful allocation
The eventual allocation also depends on how each index calculates a security's weight. Nasdaq uses the lower of a company's full market capitalization or three times its free-float-adjusted capitalization. Under its methodology, a company with a 15 per cent public float would have its index weighting limited to 45 per cent of its listed market value. S&P applies a different set of conditions, including at least 10 per cent investable float, positive GAAP net income in the latest quarter and across the preceding four quarters, and approval by its Index Committee.[5, 6]
Consequently, a company can qualify for an index without receiving an allocation proportionate to its headline valuation. A large total market capitalization does not automatically translate into an equally large pool of shares that benchmark-tracking funds must acquire. The actual investable float and the resulting index weights will determine how much purchasing is required.
This is the central uncertainty behind Intropic's 30 per cent estimate. The forecast describes potential aggregate demand, not a confirmed commitment by index funds to acquire that proportion of Anthropic's shares. The scale of any buying depends on successful admissions, effective inclusion dates and the weights assigned by individual providers. Even the earliest eligibility windows therefore represent opportunities for additional demand rather than guaranteed sources of liquidity.[1, 2]
The broader market is also moving against the prospect of an uncomplicated recovery. On November 20, Nvidia fell nearly 7 per cent, AMD declined 11.2 per cent, Sandisk lost almost 15 per cent, and Intel dropped 4.3 per cent. Anthropic's listing and Nvidia's earnings had both failed to arrest the deterioration in AI-related equities.[2, 7]
AI shares are repricing growth expectations even as Anthropic reports rapid expansion
The selling reflects greater scrutiny of the prices attached to anticipated AI growth and the substantial expenditure required to sustain it. David Miller, chief investment officer at Catalyst Funds, described investors as continuing to believe in AI while becoming more selective about the prices they are prepared to pay for its growth.[2] That interpretation allows for continued expansion in AI demand alongside falling equity valuations. Anthropic's declining share price therefore cannot, by itself, establish that the company's underlying commercial prospects have deteriorated.
Its reported operating growth remains substantial. Revenue reached $33.2bn during the first nine months of 2026, compared with $2.5bn over the corresponding period a year earlier. Anthropic also reported an annualized revenue run rate of approximately $81bn by the end of October.[8]
However, the $81bn figure represents an annualized rate, not a guarantee that the company will generate that amount in realized revenue over the following 12 months. Nor do the reported revenue figures establish operating profitability or free cash flow.[8, 9] They demonstrate substantial commercial expansion, but do not independently establish the economic returns required to support the valuation.
The valuation itself is also less straightforward than the headline suggests. Market-capitalization calculations at the opening price ranged from just under $1.5tn to slightly above $2tn, depending on the treatment of shares and other equity awards. One calculation placed Anthropic's first-day closing valuation at approximately $1.8tn when stock options and unvested awards were included.[4, 10] The $1.3tn headline cannot therefore be treated as an unambiguous measure of the company's economic value.
Passive buying could support Anthropic's share price without financing its expansion
The distinction between passive demand and business fundamentals is particularly important because index purchases would take place in the secondary market. Funds buying Anthropic shares would acquire them from other shareholders; those transactions would not constitute additional capital for Anthropic. A substantial institutional bid could improve demand for the stock without increasing the company's cash resources or demonstrating that its operating economics justify its market capitalization.
The coming trading sessions provide the first practical test. CRSP and FTSE Russell eligibility decisions after five trading days, followed by MSCI's assessment and Nasdaq's 15-day process, will establish whether the published methodologies translate into actual additions. The relevant outcomes are not simply announcements of inclusion, but the resulting index weights and subsequent fund purchases. By December 31, those purchases can be compared with Intropic's estimate of demand equivalent to as much as 30 per cent of outstanding shares.[1, 2, 5]
The share price provides a separate test. Persistent closing prices below the $83 offering reference would weaken the argument that prospective passive demand is providing effective support. A sustained recovery above the $111.50 opening price, accompanied by an improvement in broader AI equities, would indicate a different market environment. The longer-term S&P opportunity remains subject to its 12-month trading-history requirement and financial eligibility conditions, extending that potential source of demand into November 2027.[3, 5]
For now, Anthropic's existing portfolio holders have the clearest measurable exposure: almost $22.5bn already represented across publicly available investment portfolios. The additional buying that could support their holdings remains conditional on index decisions, public float and actual fund accumulation. Even if Intropic's forecast proves accurate, the resulting transactions will transfer ownership of Anthropic shares rather than strengthen the company's balance sheet. The immediate economic exposure therefore rests with shareholders already holding the stock, while Anthropic must still demonstrate that its reported revenue growth can support the valuation independently of passive investment demand.
Cover Photo: CC-BY 2.0 TechCrunch